Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 February 2026

View source ↗

Summary

PRAC has concluded its safety review of levamisole, a medicine used to treat helminthiasis, and will issue further communications on safety findings or needed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminthiasis

Drugs mentioned

• Levamisole (levamisole)

Snippet

PRAC concludes safety review of levamisole, a medicine used to treat parasitic worm infections